Brain scans reveal LSD's grip on serotonin receptors

NCT ID NCT05953038

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study uses brain imaging to measure how LSD attaches to serotonin 2A receptors in the brain. Healthy volunteers receive a small dose of LSD, and researchers track how much of the drug reaches these receptors and how it relates to the intensity of the experience. The goal is to better understand the biological basis of LSD's effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

LSD (lysergic acid diethylamide)

What this could lead to

If successful, this could help explain how LSD produces its effects on the brain, potentially guiding future research into psychedelic therapies.

What could go wrong

This is an early-phase study with only 40 healthy participants, so results may not apply to broader populations or have direct medical benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BASIC SCIENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Locations

  • Neurobiology Research Unit, Rigshospitalet

    Copenhagen, 2100, Denmark